Works about MYELOID-derived suppressor cells


Results: 1521
    1

    Role of miRNA dysregulation in sepsis.

    Published in:
    Molecular Medicine, 2022, v. 28, n. 1, p. 1, doi. 10.1186/s10020-022-00527-z
    By:
    • Formosa, Amanda;
    • Turgeon, Paul;
    • dos Santos, Claudia C.
    Publication type:
    Article
    2
    3
    4

    MAD2L1 Induces Tumor Progression through Influencing Multiple Immune Components: A Multi-Omics Analysis with Potential Inhibitor Prediction.

    Published in:
    Journal of Computational Biophysics & Chemistry, 2025, v. 24, n. 2, p. 123, doi. 10.1142/S2737416524500492
    By:
    • Soltan, Mohamed A.;
    • Eid, Refaat A.;
    • Shati, Ayed A.;
    • Al-Qahtani, Saleh M.;
    • Alqahtani, Youssef A.;
    • Dawood, Samy A.;
    • Alshehri, Mohammed A.;
    • Zaki, Mohamed Samir A.;
    • Alshaya, Dalal Sulaiman;
    • Fayad, Eman;
    • Binjawhar, Dalal Nasser;
    • Alsharif, Ghadi;
    • Eldeen, Muhammad Alaa
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26

    Resistance to Immune Checkpoint Inhibitors Secondary to Myeloid-Derived Suppressor Cells: A New Therapeutic Targeting of Haematological Malignancies.

    Published in:
    Journal of Clinical Medicine, 2021, v. 10, n. 9, p. 1919, doi. 10.3390/jcm10091919
    By:
    • Olivares-Hernández, Alejandro;
    • Figuero-Pérez, Luis;
    • Terán-Brage, Eduardo;
    • López-Gutiérrez, Álvaro;
    • Velasco, Álvaro Tamayo;
    • Sarmiento, Rogelio González;
    • Cruz-Hernández, Juan Jesús;
    • Miramontes-González, José Pablo;
    • Papadaki, Helen A.
    Publication type:
    Article
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    41
    42
    43
    44
    45
    47

    A Prospective, Single-Arm, Phase 2 Study of Modified Transarterial Chemoembolization Using Low-Dose Chemotherapy with Blank Microspheres Plus Low-Dose Lenvatinib and Microwave Ablation in Patients with Large (≥7 cm) Unresectable Hepatocellular Carcinoma: The TALEM Trial

    Published in:
    Liver Cancer (2235-1795), 2024, v. 13, n. 4, p. 438, doi. 10.1159/000536518
    By:
    • Huang, Zhi-Mei;
    • Han, Xue;
    • Wang, Jian;
    • Gu, Ling;
    • Tang, Lu;
    • Wu, Shao-Yong;
    • Di, Tian;
    • Hou, Ying-Wen;
    • Lau, Wan Yee;
    • Jiang, Yi-Quan;
    • Huang, Jin-Hua
    Publication type:
    Article
    48
    49
    50